Marco Meglio - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Marco Meglio's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Marco Meglio
Verified
Editor, NeurologyLive
Cranbury
Beats
Current AffairsHealth Entertainment & Lifestyle
Content
By Marco Meglio Verified| NeurologyLive Verified According to a new announcement, the FDA has made a major decision, approving Click Therapeutics’ CT-132 as the first prescription digital therapeutic for the preventive treatment of episodic migraine in adults.
Highlighting Early-Stage Promising Data of AAK1 Inhibitor SAT-3247 in Duchenne Muscular Dystrophy: Phil Lambert, PhD
By Phil Lambert, Marco Meglio Verified| NeurologyLive Verified WATCH TIME: 5 minutes"This is an orally available small molecule, which really matters for patients with DMD—making treatment simpler and more accessible is a huge advantage."Treating Duchenne muscular dystrophy (DMD) has been a challenge because of its progressive nature and the limited score of current therapies. While some treatments are effective in slowing progression, they don’t fully address muscle degeneration and regeneration.
Highlighting Early-Stage Promising Data of AAK1 Inhibitor SAT-3247 in Duchenne Muscular Dystrophy: Phil Lambert, PhD
By Phil Lambert, Marco Meglio Verified| NeurologyLive Verified WATCH TIME: 5 minutes"This is an orally available small molecule, which really matters for patients with DMD—making treatment simpler and more accessible is a huge advantage."Treating Duchenne muscular dystrophy (DMD) has been a challenge because of its progressive nature and the limited score of current therapies. While some treatments are effective in slowing progression, they don’t fully address muscle degeneration and regeneration.
Company Info
NeurologyLive
NeurologyLive is a multimedia platform focused on delivering the latest news and insights in the field of neurology. It serves as a valuable resource for healthcare professionals, particularly those treating neurological diseases. The platform offers a combination of print and digital media, ensuring that busy clinicians stay informed about significant developments in neurology. The services provided by NeurologyLive include breaking news on drug approvals, clinical trials, and emerging trends in neurological care. It features expert interviews with leading neurologists, offering insights into the latest research and clinical practices. The use of multimedia content makes the information accessible and engaging for its audience. NeurologyLive targets healthcare professionals such as neurologists, clinicians, and researchers. It has established strategic partnerships with organizations like the Consortium of Multiple Sclerosis Centers, enhancing its credibility and reach within the neurology community. Its comprehensive coverage and expert engagement position NeurologyLive as a trusted source for the latest developments in the field.
Cranbury, United States
+1 609-716-7777
Founded: 2018